Other Viruses Citation List: October 24 - November 6, 2014
Hepatitis B Virus
1. Anti-viral Effect of a Compound Isolated from Liriope platyphylla Against Hepatitis B Virus in Vitro. Huang, T.J., Y.C. Tsai, S.Y. Chiang, G.J. Wang, Y.C. Kuo, Y.C. Chang, Y.Y. Wu, and Y.C. Wu. Virus Research, 2014. 192: p. 16-24. PMID[25150190].
[PubMed]. OV_1024-110614.
2. In Vitro Evaluation of 9-(2-Phosphonylmethoxyethyl)adenine Ester Analogues, a Series of anti-HBV Structures with Improved Plasma Stability and Liver Release. Liao, S., S.Y. Fan, Q. Liu, C.K. Li, J. Chen, J.L. Li, Z.W. Zhang, Z.Q. Zhang, B.H. Zhong, and J.W. Xie. Archives of Pharmacology Research, 2014. 37(11): p. 1416-1425. PMID[24338503].
[PubMed]. OV_1024-110614.
3. An Aptamer Targets HBV Core Protein and Suppresses HBV Replication in HepG2.2.15 Cells. Zhang, Z., J. Zhang, X. Pei, Q. Zhang, B. Lu, X. Zhang, and J. Liu. International Journal of Molecular Medicine, 2014. 34(5): p. 1423-1429. PMID[25174447].
[PubMed]. OV_1024-110614.
Hepatitis C Virus
4. Identification of a Novel Drug Lead That Inhibits HCV Infection and Cell-to-cell Transmission by Targeting the HCV E2 Glycoprotein. Al Olaby, R.R., L. Cocquerel, A. Zemla, L. Saas, J. Dubuisson, J. Vielmetter, J. Marcotrigiano, A.G. Khan, F.V. Catalan, A.L. Perryman, J.S. Freundlich, S. Forli, S. Levy, R. Balhorn, and H.M. Azzazy. PLoS One, 2014. 9(10): p. e111333. PMID[25357246].
[PubMed]. OV_1024-110614.
5. Breadth of Neutralization and Synergy of Clinically Relevant Human Monoclonal Antibodies Against HCV Genotypes 1a, 1b, 2a, 2b, 2c, and 3a. Carlsen, T.H., J. Pedersen, J.C. Prentoe, E. Giang, Z.Y. Keck, L.S. Mikkelsen, M. Law, S.K. Foung, and J. Bukh. Hepatology, 2014. 60(5): p. 1551-1562. PMID[25043937].
[PubMed]. OV_1024-110614.
6. Clinical and in vitro Resistance to GS-9669, a Thumb Site II Nonnucleoside Inhibitor of the Hepatitis C Virus NS5B Polymerase. Dvory-Sobol, H., C. Voitenleitner, E. Mabery, T. Skurnac, E.J. Lawitz, J. McHutchison, E.S. Svarovskaia, W. Delaney, M.D. Miller, and H. Mo. Antimicrobial Agents and Chemotherapy, 2014. 58(11): p. 6599-6606. PMID[25155588].
[PubMed]. OV_1024-110614.
7. Potent Nonimmunosuppressive Cyclophilin Inhibitors with Improved Pharmaceutical Properties and Decreased Transporter Inhibition. Fu, J., M. Tjandra, C. Becker, D. Bednarczyk, M. Capparelli, R. Elling, I. Hanna, R. Fujimoto, M. Furegati, S. Karur, T. Kasprzyk, M. Knapp, K. Leung, X. Li, P. Lu, W. Mergo, C. Miault, S. Ng, D. Parker, Y. Peng, S. Roggo, A. Rivkin, R.L. Simmons, M. Wang, B. Wiedmann, A.H. Weiss, L. Xiao, L. Xie, W. Xu, A. Yifru, S. Yang, B. Zhou, and Z.K. Sweeney. Journal of Medicinal Chemistry, 2014. 57(20): p. 8503-8516. PMID[25310383].
[PubMed]. OV_1024-110614.
8. Design of Novel Rho Kinase Inhibitors Using Energy Based Pharmacophore Modeling, Shape-based Screening, in Silico Virtual Screening, and Biological Evaluation. Mishra, R.K., R. Alokam, S.M. Singhal, G. Srivathsav, D. Sriram, N. Kaushik-Basu, D. Manvar, and P. Yogeeswari. Journal of Chemical Information and Modeling, 2014. 54(10): p. 2876-2886. PMID[25254429].
[PubMed]. OV_1024-110614.
9. Endocannabinoid CB1 Antagonists Inhibit Hepatitis C Virus Production, Providing a Novel Class of Antiviral Host-targeting Agents. Shahidi, M., E.S. Tay, S.A. Read, M. Ramezani-Moghadam, K. Chayama, J. George, and M.W. Douglas. The Journal of General Virology, 2014. 95(Pt 11): p. 2468-2479. PMID[25053565].
[PubMed]. OV_1024-110614.
10. Successful Anti-scavenger Receptor Class B Type I (SR-BI) Monoclonal Antibody Therapy in Humanized Mice after Challenge with HCV Variants with in Vitro Resistance to SR-BI-targeting Agents. Vercauteren, K., N. Van Den Eede, A.A. Mesalam, S. Belouzard, M.T. Catanese, D. Bankwitz, F. Wong-Staal, R. Cortese, J. Dubuisson, C.M. Rice, T. Pietschmann, G. Leroux-Roels, A. Nicosia, and P. Meuleman. Hepatology, 2014. 60(5): p. 1508-1518. PMID[24797654].
[PubMed]. OV_1024-110614.
Herpes Simplex Virus 2
11. Antiviral Activity of Basidiomycete Mycelia against Influenza Type A (Serotype H1N1) and Herpes Simplex Virus Type 2 in Cell Culture. Krupodorova, T., S. Rybalko, and V. Barshteyn. Virologica Sinica, 2014. 29(5): p. 284-290. PMID[25358999].
[PubMed]. OV_1024-110614.
12. Antiherpes Simplex Virus Type 2 Activity of the Antimicrobial Peptide Subtilosin. Quintana, V.M., N.I. Torres, M.B. Wachsman, P.J. Sinko, V. Castilla, and M. Chikindas. Journal of Applied Microbiology, 2014. 117(5): p. 1253-1259. PMID[25087911].
[PubMed]. OV_1024-110614.
13. Short Communication: A Repeated Simian Human Immunodeficiency Virus Reverse Transcriptase/Herpes Simplex Virus Type 2 Cochallenge Macaque Model for the Evaluation of Microbicides. Kenney, J., N. Derby, M. Aravantinou, K. Kleinbeck, I. Frank, A. Gettie, B. Grasperge, J. Blanchard, M. Piatak, Jr., J.D. Lifson, T.M. Zydowsky, and M. Robbiani. AIDS Research and Human Retroviruses, 2014. 30(11): p. 1117-1124. PMID[25354024].
[PubMed]. OV_1024-110614.
Citations from the ISI Web of Knowledge Listings for O.V.
14. A Neutralizing Anti-gH/gL Monoclonal Antibody is Protective in the Guinea Pig Model of Congenital CMV Infection. Auerbach, M.R., D.H. Yan, R. Vij, J.A. Hongo, G. Nakamura, J.M. Vernes, Y.G. Meng, S. Lein, P. Chan, J. Ross, R. Carano, R. Deng, N. Lewin-Koh, M. Xu, and B. Feierbach. PLoS Pathogens, 2014. 10(4): p. e1004060. ISI[000342033600028].
[WOS]. OV_1024-110614.
15. Syntheses of Nucleosides with a 1',2'-Beta-lactam Moiety as Potential Inhibitors of Hepatitis C Virus NS5B Polymerase. Dang, Q., Z.B. Zhang, Y.F. Bai, R.J. Sun, J. Yin, T.Q. Chen, S. Bogen, V. Girijavallabhan, D.B. Olsen, and P.T. Meinke. Tetrahedron Letters, 2014. 55(40): p. 5576-5579. ISI[000342871800041].
[WOS]. OV_1024-110614.
16. Novel Indole Derivatives as Hepatitis C Virus NS5B Polymerase Inhibitors: Pharmacophore Modeling and 3D QSAR Studies. Varun, G., M. Lokesh, M. Sandeep, S. Shahbazi, and G.D. Reddy. Bangladesh Journal of Pharmacology, 2014. 9(3): p. 290-297. ISI[000343126700007].
[WOS]. OV_1024-110614.